Skip to content

Effect of Enhanced External Counterpulsation on Carotid Plaque Stability in Patients with Carotid Atherosclerosis

Effect of Enhanced External Counterpulsation on Carotid Plaque Stability in Patients with Carotid Atherosclerosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026435
Enrollment
Unknown
Registered
2019-10-09
Start date
2019-10-15
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid atherosclerosis

Interventions

Group 1:Received a complete EECP course (cuff pressures of 300mmHg ) based on the standard drug treatment
Group 2:Received a complete EECP course (cuff pressures of 70mmHg) based on the standard drug treatment

Sponsors

The Eighth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 21-75 years. 2. Patients with Carotid plaque (MRI type: III-VIII), no surgical indications. 3. Can accept and cooperate with more than half a year of follow-up. 4. Informed consent form approved by the Ethics Committee.

Exclusion criteria

Exclusion criteria: 1. Significant aortic regurgitation, aortic aneurysm, and dissection aneurysm; 2. Coronary artery spasm or severe coronary aneurysm; 3. Symptomatic congestive heart failure; 4. Heart valve disease, congenital heart disease, cardiomyopathy; 5. Cerebral hemorrhage within half a year, hemorrhagic disease or clear bleeding tendency; 6. Lower extremity infection, phlebitis, severe varicose veins, deep vein thrombosis; 7. Progressive malignancy or serious disease with poor prognosis; 8. Systolic blood pressure >= 180mmHg, or diastolic blood pressure >= 110mmHg when randomly grouped; 9. Severe arrhythmia affecting EECP therapy; 10. Implanted cardiac pacemaker; 11. Claustrophobia, epilepsy.

Design outcomes

Primary

MeasureTime frame
Fiber cap integrity and thickness;Volume percentage change of carotid plaque;

Secondary

MeasureTime frame
Ipsilateral cerebral infarction;Flow mediated dilatation;Ankle brachial index;Carotid plaque morphology and acoustic changes;Blood lipid;Serum inflammatory markers;

Countries

China

Contacts

Public ContactGuifu Wu

The Eighth Affiliated Hospital, Sun Yat-Sen University

wuguifu@mail.sysu.edu.cn+86 15989893111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026